Replica Analytics - An Aetion Company

New Publication: Validating a Membership Disclosure Metric for Synthetic Health Data

By Lucy Mosquera | Posted On: October 11, 2022 We have just had a paper published in JAMIA Open, entitled Validating A Membership Disclosure Metric For Synthetic Health Data, the paper validates and demonstrates, using several large datasets, how to apply a membership disclosure metric for synthetic health data, which is important for assessing the […]

Replica Analytics publishes comprehensive Cardinal Methodology for measuring and managing identity disclosure risks of datasets

OTTAWA, September 14, 2022 — A new book being published by Replica Analytics, an Aetion company, offers a complete and contemporary risk assessment methodology for accurately measuring and effectively managing the risks associated with sharing health data for secondary purposes. To innovate and improve healthcare, organizations need to leverage data, but they can face challenges sharing […]

C-Path and Replica Analytics Collaboration Aims to Accelerate Rare Disease Research

NEW YORK, OTTAWA and TUCSON, Ariz., June 29, 2022 — Critical Path Institute (C-Path) and Replica Analytics, an Aetion company, announced today a new partnership that involves leveraging synthetic data to further catalyze the generation of actionable solutions to accelerate drug development for rare diseases. Replica Analytics will help generate synthetic datasets across rare and […]